guanidinoacetic acid

Small moleculeexperimental

Glycocyamine is a metabolite of glycine in which the amino group has been converted into a guanidine by guanylation. In vertebrate organism it is then transformed into creatine by methylation. — Wikipedia

Clinical trial activity

4 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Mar 1, 2010 (NCT01133899)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2011

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

NC(=N)NCC(O)=O
Mol. weight
117.1066 g/mol

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • glycine, n-(aminoiminomethyl)-
  • glycocyamine
  • glycocyamine, 2-(14)c-labeled
  • glycocyamine, ion (1-)
  • glycocyamine monohydrochloride
  • guanidinoacetate
  • guanidinoacetic acid
  • guanidinoacetic acid
  • guanidinoacetic acid
  • guanidoacetic acid
  • n-amidinoglycine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04652921N/ASep 15, 2020University of Novi Sad
NCT02213679N/AAug 1, 2014Center for Health, Exercise and Sport Sciences, Serbia, Faculty of Sport and Physical Education, Novi Sad
NCT01371357Phase 3May 1, 2011Center for Health, Exercise and Sport Sciences, Serbia
NCT01133899Phase 1/Phase 2 (Phase 2)Mar 1, 2010Metropolitan University
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Center for Health, Exercise and Sport Sciences, SerbiaGovernment2222011
Faculty of Sport and Physical Education, Novi SadAcademic/Hospital1012014
Metropolitan UniversityAcademic/Hospital1112010
University of Novi SadAcademic/Hospital1112020
4 organizations
Page 1 / 1